Federation Des Caisses Desjardins Du Quebec Tenaya Therapeutics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 4,800 shares of TNYA stock, worth $2,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,800
Previous 4,800
-0.0%
Holding current value
$2,832
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$5.55 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$3.97 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$3.49 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$2.41 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2.4 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $24.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...